← Back to Bill Feed
FederalIn Committee

PEAT Act of 2026

Introduced Apr 30, 2026 · Last action Apr 30, 2026 Referred to the House Committee on Energy and Commerce.

Track this bill

Save bills and get alerts when status changes.

Sign in to saved bills.

Summary

This legislation is called the PEAT Act of 2026. Referred to the House Committee on Energy and Commerce.

Full bill text

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8630 Introduced in House (IH)]

<DOC>

119th CONGRESS
  2d Session
                                H. R. 8630

   To amend the Public Health Service Act to prohibit treatment of a
  biologic as a biological product based solely on the presence of a
 protein that is a clinically inactive component in such biologic, and
                          for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 30, 2026

 Mr. Rulli (for himself and Mrs. Harshbarger) introduced the following
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

   To amend the Public Health Service Act to prohibit treatment of a
  biologic as a biological product based solely on the presence of a
 protein that is a clinically inactive component in such biologic, and
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Equal Access to Thyroid
Act of 2026'' or the ``PEAT Act of 2026''.

SEC. 2. PROHIBITION WITH RESPECT TO TREATMENT OF PROTEINS IN BIOLOGICS.

    (a) In General.--Section 351(i)(1) of the Public Health Service Act
(42 U.S.C. 262(i)(1)) is amended--
            (1) by striking ``The term'' and inserting the following:
                    ``(A) The term''; and
            (2) by adding at the end the following:
                    ``(B) A biologic described in subparagraph (A) may
                not be treated as a biological product based solely on
                the presence of a protein that is a clinically inactive
                component in such biologic.''.
    (b) Technical Correction.--Section 351(i)(1) of the Public Health
Service Act (42 U.S.C. 262(i)(1)) is amended in subparagraph (A), as
designated by subsection (a)(1), by striking ``protein ,'' and
inserting ``protein,''.
                                 <all>

Official legislative text sourced from the public record (cached on CivicsHQ).

Official source

View the original bill, actions, and full legislative record on Congress.gov.

View on Congress.govopen_in_new

Status

In Committee

  1. 1Introduced
  2. 2Committee
  3. 3Floor
  4. 4Passed
  5. 5Signed

Timeline reflects current normalized status only. Full action history is not yet stored in the API.

Votes

Voting records are not yet available for this bill.